The interferon-inducible gene viperin restricts West Nile virus pathogenesis

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11557-11566

  Szretter, Kristy J ^a   Brien, James D ^a   Thackray, Larissa B ^a   Virgin, Herbert W ^a   Cresswell, Peter ^b   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD11B ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GENE PRODUCT; GRANZYME B; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIPERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BONE MARROW CELL; BRAIN CELL; BRAIN CORTEX; BRAIN STEM; BRAIN TISSUE; CD3+ CD4+ T CELL; CD3+ CD8+ T CELL; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELL VIABILITY; CEREBELLUM; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; FIBROBLAST; GENE; GRAY MATTER; HIPPOCAMPUS; INTERFERON INDUCIBLE GENE; KIDNEY; LETHALITY; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPINAL CORD; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TISSUE SPECIFICITY; VIPERIN GENE; VIREMIA; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WHITE MATTER;

ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; FIBROBLASTS; INTERFERONS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PROTEINS; SURVIVAL ANALYSIS; WEST NILE VIRUS;

MUS; WEST NILE VIRUS;

EID: 80655146257     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05519-11     Document Type: Article

References (64)

1. Austin, B. A., C. James, R. H. Silverman, and D. J. Carr. 2005. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J. Immunol. 175: 1100-1106.
2. Boulant, S., P. Targett-Adams, and J. McLauchlan. 2007. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 88:2204-2213.
3. Brien, J. D., J. L. Uhrlaub, and J. Nikolich-Zugich. 2007. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37:1855-1863.
4. Brown, A. N., K. A. Kent, C. J. Bennett, and K. A. Bernard. 2007. Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 368:422-430.
5. Busch, M. P., et al. 2006. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis. 12:395-402.
6. Chan, Y. L., T. H. Chang, C. L. Liao, and Y. L. Lin. 2008. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J. Virol. 82:10455- 10464.
7. Chin, K. C., and P. Cresswell. 2001. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 98:15125-15130.
8. Daffis, S., M. A. Samuel, B. C. Keller, M. Gale, Jr., and M. S. Diamond. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog. 3:e106.
9. Delhaye, S., et al. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103:7835-7840.
10. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623-15628.
11. Diamond, M. S. 2009. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J. Interferon Cytokine Res. 29:521-530.
12. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578-2586.
13. Duschene, K. S., and J. B. Broderick. 2010. The antiviral protein viperin is a radical SAM enzyme. FEBS Lett. 584:1263-1267.
14. Ebel, G. D., J. Carricaburu, D. Young, K. A. Bernard, and L. D. Kramer. 2004. Genetic and phenotypic variation of West Nile virus in New York, 2002-2003. Am. J. Trop. Med. Hyg. 71:493-500.
15. Elbahesh, H., B. K. Jha, R. H. Silverman, S. V. Scherbik, and M. A. Brinton. 2011. The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells. Virology 409:262-270.
16. Fitzgerald, K. A. 2011. The interferon inducible gene: viperin. J. Interferon Cytokine Res. 31:131-135.
17. Fuchs, A., A. K. Pinto, W. J. Schwaeble, and M. S. Diamond. 2011. The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412:101-109.
18. Glass, W. G., et al. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202:1087-1098.
19. Hayes, E. B., et al. 2005. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 11:1167-1173.
20. Helbig, K. J., D. T. Lau, L. Semendric, H. A. Harley, and M. R. Beard. 2005. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42:702-710.
21. Hinson, E. R., and P. Cresswell. 2009. The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc. Natl. Acad. Sci. U. S. A. 106:20452-20457.
22. Hinson, E. R., and P. Cresswell. 2009. The N-terminal amphipathic alphahelix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J. Biol. Chem. 284:4705-4712.
23. Hinson, E. R., et al. 2010. Viperin is highly induced in neutrophils and macrophages during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 184:5723-5731.
24. Jiang, D., et al. 2008. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 82:1665- 1678.
25. Jiang, D., et al. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84:8332-8341.
26. Kajaste-Rudnitski, A., et al. 2006. The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J. Biol. Chem. 281:4624-4637.
27. Klein, R. S., et al. 2005. Neuronal CXCL10 directs CD8+ T cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
28. Lazear, H. M., A. K. Pinto, M. R. Vogt, M. Gale, Jr., and M. S. Diamond. 2011. Beta interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 85:7186-7194.
29. Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe et al. (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
30. Liu, S. Y., D. J. Sanchez, and G. Cheng. 2011. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 23:57-64.
31. Malathi, K., B. Dong, M. Gale, Jr., and R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816-819.
32. Malathi, K., et al. 2010. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16:2108-2119.
33. Mashimo, T., et al. 2002. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. U. S. A. 99:11311-11316.
34. Mehlhop, E., and M. S. Diamond. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
35. Miyanari, Y., et al. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
36. Oliphant, T., et al. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11:522-530.
37. Perelygin, A. A., et al. 2002. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. U. S. A. 99:9322-9327.
38. Petersen, L. R., A. A. Marfin, and D. J. Gubler. 2003. West Nile virus. JAMA 290:524-528.
39. Purtha, W. E., et al. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37:1845-1854.
40. Qiu, L. Q., P. Cresswell, and K. C. Chin. 2009. Viperin is required for optimal Th2 responses and T-cell receptor-mediated activation of NFkappaB and AP-1. Blood 113:3520-3529.
41. Rivieccio, M. A., et al. 2006. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 177:4735-4741.
42. Saitoh, T., et al. 2011. Antiviral protein viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 34:352-363.
43. Samsa, M. M., et al. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5:e1000632.
44. Samuel, M. A., and M. S. Diamond. 2006. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80:9349-9360.
45. Samuel, M. A., and M. S. Diamond. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361.
46. Samuel, M. A., et al. 2006. PKR and RNase L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80:7009-7019.
47. Scherbik, S. V., K. Kluetzman, A. A. Perelygin, and M. A. Brinton. 2007. Knock-in of the Oas1b (r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype. Virology 368:232-237.
48. Schoggins, J. W., et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
49. Schulz, O., et al. 2010. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7:354-361.
50. Seo, J. Y., R. Yaneva, E. R. Hinson, and P. Cresswell. 2011. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 332:1093-1097.
51. Severa, M., E. M. Coccia, and K. A. Fitzgerald. 2006. Toll-like receptordependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 281:26188-26195.
52. Shaveta, G., J. Shi, V. T. Chow, and J. Song. 2010. Structural characterization reveals that viperin is a radical S-adenosyl-L-methionine (SAM) enzyme. Biochem. Biophys. Res. Commun. 391:1390-1395.
53. Shrestha, B., and M. S. Diamond. 2004. The role of CD8+ T cells in the control of West Nile virus infection. J. Virol. 78:8312-8321.
54. Shrestha, B., D. I. Gottlieb, and M. S. Diamond. 2003. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 77:13203-13213.
55. Simon-Chazottes, D., et al. 2011. Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis. Virology 417:147-153.
56. Suthar, M. S., et al. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757.
57. Szretter, K. J., et al. 2010. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 84:12125-12138.
58. Szretter, K. J., et al. 2009. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile virus pathogenesis. J. Virol. 83:9329-9338.
59. Town, T., et al. 2009. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30:242-253.
60. Wang, X., E. R. Hinson, and P. Cresswell. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96-105.
61. Wang, Y., M. Lobigs, E. Lee, and A. Mullbacher. 2003. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-13334.
62. Wilkins, C., and M. Gale, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41-47.
63. Zhang, Y., C. W. Burke, K. D. Ryman, and W. B. Klimstra. 2007. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81:11246-11255.
64. Zhu, H., J. P. Cong, and T. Shenk. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U. S. A. 94:13985-13990.